254 related articles for article (PubMed ID: 15197447)
1. [Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors].
Porst H
Urologe A; 2004 Jul; 43(7):820-8. PubMed ID: 15197447
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
Chen Q; Wang N; Yao F; Lu X
Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
[TBL] [Abstract][Full Text] [Related]
3. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
Gresser U; Gleiter CH
Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
[TBL] [Abstract][Full Text] [Related]
4. PDE5 inhibitors: are there differences?
Carson CC
Can J Urol; 2006 Feb; 13 Suppl 1():34-9. PubMed ID: 16526979
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
Berner MM; Kriston L; Harms A
Int J Impot Res; 2006; 18(3):229-35. PubMed ID: 16239897
[TBL] [Abstract][Full Text] [Related]
6. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 5 inhibitors for erectile dysfunction.
Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of erectile dysfunction in 2005].
Porst H
Urologe A; 2003 Oct; 42(10):1330-6. PubMed ID: 14569381
[TBL] [Abstract][Full Text] [Related]
9. [How effective are PDE-5 inhibitors?].
Jünemann KP
Urologe A; 2003 Apr; 42(4):553-8. PubMed ID: 12715127
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
Carson CC; Lue TF
BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
[TBL] [Abstract][Full Text] [Related]
11. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
[TBL] [Abstract][Full Text] [Related]
12. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
Montorsi F; Corbin J; Phillips S
J Sex Med; 2004 Nov; 1(3):322-36. PubMed ID: 16422964
[TBL] [Abstract][Full Text] [Related]
13. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
Katsarov M
Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
[No Abstract] [Full Text] [Related]
14. Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies.
Padma-Nathan H; McCullough A; Forest C
Curr Urol Rep; 2004 Dec; 5(6):467-71. PubMed ID: 15541217
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of PDE5 inhibitors.
Rashid A
Clin Cornerstone; 2005; 7(1):47-56. PubMed ID: 16156423
[TBL] [Abstract][Full Text] [Related]
16. [Sex, erectile dysfunction, and the heart: a growing problem].
Görge G; Flüchter S; Kirstein M; Kunz T
Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey.
Kim NN
Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572
[TBL] [Abstract][Full Text] [Related]
18. An update on the PDE-5 inhibitors (PDE-5i).
McCullough AR
J Androl; 2003; 24(6 Suppl):S52-8. PubMed ID: 14581496
[No Abstract] [Full Text] [Related]
19. Future options for combination therapy in the management of erectile dysfunction in older men.
Sommer F; Engelmann U
Drugs Aging; 2004; 21(9):555-64. PubMed ID: 15260511
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists.
Francis SH; Corbin JD
Curr Urol Rep; 2003 Dec; 4(6):457-65. PubMed ID: 14622499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
